Next Article in Journal
Comparative Analysis between the In Vivo Biodistribution and Therapeutic Efficacy of Adipose-Derived Mesenchymal Stromal Cells Administered Intraperitoneally in Experimental Colitis
Next Article in Special Issue
Mitochondrial Dysfunctions in Type I Endometrial Carcinoma: Exploring Their Role in Oncogenesis and Tumor Progression
Previous Article in Journal
Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors
Previous Article in Special Issue
Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level

Pathogenomics of Endometriosis Development

D.O.Ott Institute of Obstetrics, Gynecology and Reproductology, Saint-Petersburg 199034, Russia
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(7), 1852;
Received: 24 May 2018 / Revised: 10 June 2018 / Accepted: 21 June 2018 / Published: 23 June 2018
(This article belongs to the Special Issue Molecular Research of Endometrial Pathophysiology)
For over 100 years, endometriosis, as a chronic, estrogen-dependent, inflammatory, heritable disease affecting approximately 5–10% of women in reproductive age has been the focus of clinicians and scientists. In spite of numerous environmental, genetic, epigenetic, endocrine, and immunological studies, our knowledge of endometriosis is still fragmentary, and its precise pathophysiology and pathogenomics remain a mystery. The implementation of new technologies has provided tremendous progress in understanding the many intrinsic molecular mechanisms in the development of endometriosis, with progenitor and stem cells (SCs) of the eutopic endometrium as the starting players and endometriotic lesions as the final pathomorphological trait. Novel data on the molecular, genetic, and epigenetic mechanisms of the disease are briefly outlined. We hypothesize the existence of an endometriosis development genetic program (EMDP) that governs the origin of endometrium stem cells programmed for endometriosis (1), their transition (metaplasia) into mesenchymal SCs (2), and their invasion of the peritoneum and progression to endometriotic lesions (3). The pros and cons of the recent unifying theory of endometriosis are also discussed. Complex genomic and epigenetic interactions at different stages of the endometriosis process result in different forms of the disease, with specific features and clinical manifestations. The significance of the EMDP in elaborating a new strategy for endometriosis prediction, prevention, and treatment is discussed. View Full-Text
Keywords: endometriosis; developmental pathway; pathogenomics; mesenchymal stem cells endometriosis; developmental pathway; pathogenomics; mesenchymal stem cells
Show Figures

Figure 1

MDPI and ACS Style

Baranov, V.; Malysheva, O.; Yarmolinskaya, M. Pathogenomics of Endometriosis Development. Int. J. Mol. Sci. 2018, 19, 1852.

AMA Style

Baranov V, Malysheva O, Yarmolinskaya M. Pathogenomics of Endometriosis Development. International Journal of Molecular Sciences. 2018; 19(7):1852.

Chicago/Turabian Style

Baranov, Vladislav; Malysheva, Olga; Yarmolinskaya, Maria. 2018. "Pathogenomics of Endometriosis Development" Int. J. Mol. Sci. 19, no. 7: 1852.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop